OnCore Biopharma

About:

OnCore Biopharma, Inc. is a privately held biotechnology company.

Website: http://www.oncorebiopharma.com/

Description:

OnCore Biopharma, Inc. is a privately held biotechnology company focused on the research, development, and commercialization of therapies for the treatment of chronic hepatitis B virus (HBV) infection. OnCore has assembled a portfolio of novel product candidates with unique mechanisms of action for the treatment of hepatitis B and is focused on delivering a cure.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Doylestown, Pennsylvania, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)oncorebiopharma.com

Founders:

Michael J. McElhaugh, Michael Sofia, Patrick Higgins

Number of Employees:

11-50

Last Funding Date:

2014-10-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai